Inventor
JENNINGS ANDREW
US22 patents
⚠️ This page may combine multiple inventors who share the name “JENNINGS ANDREW”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GASHERBRUM BIO INC
8 patentsUS11926626B2Mar 12, 2024
Heterocyclic GLP-1 agonists
GASHERBRUM BIO INC7 citations84
US11492365B2Nov 8, 2022
Heterocyclic GLP-1 agonists
GASHERBRUM BIO INC6 citations84
US12221442B2Feb 11, 2025
Heterocyclic GLP-1 agonists
GASHERBRUM BIO INC3 citations73
US11897851B2Feb 13, 2024
Heterocyclic GLP-1 agonists
GASHERBRUM BIO INC3 citations73
US12528781B2Jan 20, 2026
Heterocyclic GLP-1 agonists
GASHERBRUM BIO INC0 citations61
US11926643B2Mar 12, 2024
Heterocyclic GLP-1 agonists
GASHERBRUM BIO INC0 citations61
US12595264B2Apr 7, 2026
Heterocyclic GLP-1 agonists
GASHERBRUM BIO INC0 citations50
US12552791B2Feb 17, 2026
Heterocyclic GLP-1 agonists
GASHERBRUM BIO INC0 citations50
MERCK SHARP & DOHME
5 patentsUS6642229B2Nov 4, 2003
3-Phenyl-imidazo-pyrimidine derivatives as ligands for GABA receptors
MERCK SHARP & DOHME21 citations92
US6936608B2Aug 30, 2005
Imidazo-triazine derivatives as ligands for GABA receptors
MERCK SHARP & DOHME20 citations90
US6900215B2May 31, 2005
Imidazo-pyrimidine derivatives as ligands for gaba receptors
MERCK SHARP & DOHME16 citations83
US6969716B2Nov 29, 2005
5-phenyl[1,2,4]triazines as ligands for GABA-A α2/α3 receptors for treating anxiety or depression
MERCK SHARP & DOHME6 citations62
US7655644B2Feb 2, 2010
Piperidine and azetidine derivatives as GlyT1 inhibitors
MERCK SHARP & DOHME0 citations39